ALPHA TRIBE

Aurobindo Pharma LimitedUpdates, 21-08-2026: General Updates

21-08-2026 | 03:34 pm

Aurobindo Pharma's subsidiary, AuroPeptides, completed a US FDA inspection with only one observation regarding facility maintenance. This observation does not relate to data integrity or GMP compliance, and corrective action has been initiated, affirming robust quality standards.

No comments yet. Be the first to comment!

All announcements from Aurobindo Pharma Limited